SOURCE: Kalorama Information
December 12, 2008 08:40 ET
Shortfall in Human Blood Supply Spurs Innovation in Synthetic Substitutes
NEW YORK, NY--(Marketwire - December 12, 2008) - The market for human blood and blood
components continues to expand in correlation with the world's growing and
aging populations, particularly in the United States, Japan, and Europe.
According to a new report from Kalorama Information entitled "Blood: The
Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and
Synthetic Blood Products," a shortfall in human blood supply is prompting
the development of synthetic blood products.
Demand for blood increases about 6% annually, and earned revenues of about
$16 billion in 2007. Though global demand has increased over the last
decade, supply has declined. The current worldwide supply of blood for
transfusions is 60 million pints per year, while worldwide demand is 180
million pints per year.
"In the U.S. alone, the 65 and older segment is expected to double in the
next 30 years," says Bruce Carlson, publisher of Kalorama Information. "And
while the Baby Boomer population ages and requires more blood, the prime
donor age population will shrink, exacerbating the shortfall."
Innovation in synthetic blood products is an integral component to
addressing the shortfall between blood supply and demand. Such products are
not dependent on voluntary donations and can be manufactured in quantities
to meet demand.
Some synthetic products such as recombinant factors, with $5.6 billion in
2007 sales, are well established and projected to grow 9% annually through
2012. Others, such as
hemoglobin-based oxygen carriers (HBOCs) and perflurocarbon-based oxygen
carriers (PFCs), are expected to enter the market by 2010 and projected to
reach nearly $1 billion by 2014.
Synthetic blood substitutes have long been sought for treatment of chronic
and acute anemias and for the rapid replacement of blood lost after trauma.
They are commonly used in a variety of other applications including
elective surgery, cardiovascular surgery, chemotherapy, and sickle cell
crisis.
"Blood: The Worldwide Market for Blood Products, Blood Testing, Blood
Equipment, and Synthetic Blood Products" features a comprehensive analysis
of the blood industry including products, equipment and testing; discusses
key trends and regulatory, business, and clinical challenges, and contains
complete market data with forecasts through 2014. For further information
visit:
http://www.kaloramainformation.com/redirect.asp?progid=15112&productid=1816262.
About Kalorama Information
Kalorama Information supplies the latest in independent market research in
the life sciences, as well as a full range of custom research services. We
routinely assist the media with healthcare topics.